Wednesday, May 04, 2022 7:06:06 AM
Share Share
Tweet Tweet
Forward Forward
Progressive Care Gains Long Term Care Contracts with Major Payors
See on website
MIAMI, FL – May 4, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce its long term care division gained all the necessary long-term care contracts with major payors.
“Our long history of enhanced patient care, as well as robust data management platform and logistics network are key elements that will facilitate the success of our long-term care business. The long-term care pharmacy contracts provide Progressive Care with an opportunity to significantly increase its sales that produce much better margins. Our Chief Operating Officer, Birute Norkute, has successfully executed on completing this complicated and tidies process and instituting final and imperative steps for the successful launch of our LTC marketing program. We are excited about LTC business and confident in our ability to deliver strong results.” Stated Jay Weisberg, CEO of Progressive Care Inc.
PharmcoRx long-term care division pharmacy services include a combination of adherence tools, clinical pharmacy services, patient navigation and engagement, real-time collaboration with the patient’s caregivers, medication reconciliation post-discharge, monthly medication reviews, 24/7 access to clinical pharmacy support through the Company’s online platform, automated Rx refill management, specialty adherence packaging that includes the Company’s successful Smart-Pack adherence packaging and free same-day delivery.
Carlos Rangel, Head of Digital Transformation of Progressive Care Inc. stated “The expansion into long-term care will complement perfectly with the company’s recently announced plan to expand into a Remote Patient Monitoring space. The capability to provide real-time insights from the high-risk patients will not only help physicians make well-informed decisions but will also enhance the patient experience and promote positive outcomes in a long-term care setting.”
For more information about Progressive Care, please visit the company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com
PharmCo Rx Pharmacy
https://www.pharmcorx.com
ClearMetrX
https://www.clearmetrx.com
Forward-Looking Statements:
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
ClearThink Capital
nyc@clearthink.capital
Find Out More
Link
Website
Copyright © 2022 Progressive Care, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Progressive Care
901 North Miami Beach Blvd
Suite 1 and 2
North Miami Beach, FL 33162
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Email Marketing Powered by Mailchimp
Recent RXMD News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 03:51:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/06/2024 08:54:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 07:54:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 04:38:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 04:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:40:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:34:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:20:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:04:51 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM